• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫功能正常患者的孤立性肺毛霉病:病例报告和文献系统回顾。

Isolated pulmonary mucormycosis in an immunocompetent patient: a case report and systematic review of the literature.

机构信息

Department of Respiratory and Critical Care Medicine, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Jie Fang Road, Han Kou District, Wu Han, 1095430030, HuBei Province, China.

Department of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Avenue 1095, Wuhan, 430030, China.

出版信息

BMC Pulm Med. 2021 Apr 27;21(1):138. doi: 10.1186/s12890-021-01504-8.

DOI:10.1186/s12890-021-01504-8
PMID:33906622
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8077830/
Abstract

BACKGROUND

Pulmonary mucormycosis caused by Mucorales is a highly lethal invasive fungal infection usually found in immunocompromised patients. Isolated pulmonary mucormycosis in immunocompetent patients is very rare. Here, we present a case of a 32-year-old male who developed pulmonary mucormycosis without any known immunodeficiency.

CASE PRESENTATION

The patient presented to our hospital because of cough and chest pain along with blood in the sputum. He was first treated for community-acquired pneumonia until bronchoalveolar lavage fluid culture confirmed the growth of Absidia. His symptoms were relieved with the use of amphotericin B, and he eventually recovered. We also provide a systematic review of relevant literature to summarize the characteristics of pulmonary mucormycosis in immunocompetent patients.

CONCLUSIONS

Pulmonary mucormycosis has variable clinical presentations and is difficult to identify. Due to its high fatality rate, clinicians should make judgements regarding suspected cases correctly and in a timely manner to avoid misdiagnosis and delayed treatment.

摘要

背景

毛霉目引起的肺部毛霉菌病是一种高度致命的侵袭性真菌感染,通常发生在免疫功能低下的患者中。免疫功能正常的患者中孤立性肺部毛霉菌病非常罕见。在这里,我们报告了一例 32 岁男性患者,他患有肺部毛霉菌病,但没有任何已知的免疫缺陷。

病例介绍

该患者因咳嗽、胸痛和痰中带血到我院就诊。他最初被诊断为社区获得性肺炎,直到支气管肺泡灌洗液培养确认了棘孢木霉的生长。他使用两性霉素 B 治疗后症状得到缓解,最终康复。我们还对相关文献进行了系统回顾,以总结免疫功能正常患者肺部毛霉菌病的特征。

结论

肺部毛霉菌病的临床表现多样,难以识别。由于其高死亡率,临床医生应及时正确地对疑似病例做出判断,避免误诊和治疗延误。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7102/8077830/571631ddc11a/12890_2021_1504_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7102/8077830/37a63bd80d13/12890_2021_1504_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7102/8077830/40bfe3093a3f/12890_2021_1504_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7102/8077830/571631ddc11a/12890_2021_1504_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7102/8077830/37a63bd80d13/12890_2021_1504_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7102/8077830/40bfe3093a3f/12890_2021_1504_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7102/8077830/571631ddc11a/12890_2021_1504_Fig3_HTML.jpg

相似文献

1
Isolated pulmonary mucormycosis in an immunocompetent patient: a case report and systematic review of the literature.免疫功能正常患者的孤立性肺毛霉病:病例报告和文献系统回顾。
BMC Pulm Med. 2021 Apr 27;21(1):138. doi: 10.1186/s12890-021-01504-8.
2
lung infection in an immunocompetent patient successfully treated with amphotericin B: A case report.免疫功能正常的患者肺部感染,用两性霉素B成功治疗:一例报告。
World J Clin Cases. 2021 Dec 16;9(35):11108-11114. doi: 10.12998/wjcc.v9.i35.11108.
3
[Mixed invasive fungal infection due to Rhizomucor pusillus and Aspergillus niger in an immunocompetent patient].[免疫功能正常患者发生米根霉和黑曲霉混合性侵袭性真菌感染]
Rev Iberoam Micol. 2015 Jan-Mar;32(1):46-50. doi: 10.1016/j.riam.2013.03.002. Epub 2013 Apr 11.
4
Isolated Pulmonary Mucormycosis in an immunocompetent patient.免疫功能正常患者的孤立性肺毛霉菌病。
Rev Port Cir Cardiotorac Vasc. 2019 Apr-Jun;26(2):151-153.
5
Invasive pulmonary mucormycosis: rare presentation with pulmonary eosinophilia.侵袭性肺毛霉病:伴有肺嗜酸性粒细胞增多症的罕见表现。
BMC Pulm Med. 2017 Apr 28;17(1):76. doi: 10.1186/s12890-017-0419-1.
6
Pulmonary mucormycosis: radiologic findings in 32 cases.肺毛霉菌病:32例的影像学表现
AJR Am J Roentgenol. 1997 Jun;168(6):1541-8. doi: 10.2214/ajr.168.6.9168721.
7
Clinical spectrum of pulmonary mucormycosis.肺毛霉病的临床谱
Chest. 1986 Mar;89(3):435-9. doi: 10.1378/chest.89.3.435.
8
Pulmonary mucormycosis in immunocompetent hosts diagnosed by bronchioalveolar lavage.通过支气管肺泡灌洗诊断免疫功能正常宿主的肺毛霉菌病。
BMJ Case Rep. 2021 Apr 12;14(4):e240180. doi: 10.1136/bcr-2020-240180.
9
A case of pulmonary mucormycosis presented as Pancoast syndrome and bone destruction in an immunocompetent adult mimicking lung carcinoma.一例肺毛霉菌病表现为 Pancoast 综合征和骨质破坏,在免疫功能正常的成人中类似于肺癌。
J Mycol Med. 2019 Apr;29(1):80-83. doi: 10.1016/j.mycmed.2018.10.005. Epub 2018 Dec 12.
10
Pulmonary mucormycosis in a patient with acute liver failure: A case report and systematic review of the literature.急性肝衰竭患者肺部毛霉病:病例报告及文献系统回顾。
J Crit Care. 2020 Apr;56:89-93. doi: 10.1016/j.jcrc.2019.12.012. Epub 2019 Dec 12.

引用本文的文献

1
Aggressive Management of Pulmonary Mucormycosis Necrotizing Fasciitis in a Post-Liver Transplant Patient.肝移植术后患者侵袭性肺毛霉菌病坏死性筋膜炎的积极治疗
Cureus. 2025 Feb 6;17(2):e78649. doi: 10.7759/cureus.78649. eCollection 2025 Feb.
2
Pulmonary mucormycosis in an immunocompetent young female: a case report and literature review.免疫功能正常的年轻女性患肺毛霉菌病:一例报告及文献综述
Front Med (Lausanne). 2024 Dec 24;11:1491489. doi: 10.3389/fmed.2024.1491489. eCollection 2024.
3
Diagnostic Challenges in Rhino-Orbito-Cerebral Mucormycosis With Diabetes Mellitus, Hypertensive Emergency, and Excess Alcohol Consumption.

本文引用的文献

1
Pulmonary mucormycosis in a patient with acute liver failure: A case report and systematic review of the literature.急性肝衰竭患者肺部毛霉病:病例报告及文献系统回顾。
J Crit Care. 2020 Apr;56:89-93. doi: 10.1016/j.jcrc.2019.12.012. Epub 2019 Dec 12.
2
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium.侵袭性真菌病的共识定义修订与更新:来自欧洲癌症研究与治疗组织和真菌病研究组教育与研究联合会。
Clin Infect Dis. 2020 Sep 12;71(6):1367-1376. doi: 10.1093/cid/ciz1008.
3
合并糖尿病、高血压急症及过量饮酒的鼻眶脑型毛霉菌病的诊断挑战
Cureus. 2024 Nov 28;16(11):e74663. doi: 10.7759/cureus.74663. eCollection 2024 Nov.
4
Fatal Tracheal and Bronchial Destruction Due to Pulmonary Mucormycosis in a 20-Year-Old with Diabetic Ketoacidosis.一名20岁糖尿病酮症酸中毒患者因肺毛霉菌病导致致命性气管和支气管破坏
Infect Drug Resist. 2024 Dec 6;17:5429-5437. doi: 10.2147/IDR.S493002. eCollection 2024.
5
A case of pulmonary co-infection with and Mucorales in a patient with sarcoidosis.结节病患者合并肺毛霉目真菌感染一例。
Respir Med Case Rep. 2024 Oct 17;52:102130. doi: 10.1016/j.rmcr.2024.102130. eCollection 2024.
6
To determine the role of transcutaneous retrobulbar amphotericin B in COVID-19-related rhino-orbital-cerebral mucormycosis.确定经皮球后注射两性霉素B在新型冠状病毒肺炎相关鼻眶脑毛霉菌病中的作用。
Oman J Ophthalmol. 2024 Jun 27;17(2):198-204. doi: 10.4103/ojo.ojo_19_23. eCollection 2024 May-Aug.
7
Oral Isavuconazole Combined with Nebulized Inhalation and Bronchoscopic Administration of Amphotericin B for the Treatment of Pulmonary Mucormycosis: A Case Report and Literature Review.口服艾沙康唑联合雾化吸入及支气管镜下两性霉素B给药治疗肺毛霉病:1例报告及文献复习
J Fungi (Basel). 2024 May 29;10(6):388. doi: 10.3390/jof10060388.
8
Alternative models of mucormycosis.其他毛霉病模型。
Front Cell Infect Microbiol. 2024 Feb 1;14:1343834. doi: 10.3389/fcimb.2024.1343834. eCollection 2024.
9
Social determinants of health as drivers of fungal disease.作为真菌病驱动因素的健康的社会决定因素
EClinicalMedicine. 2023 Nov 18;66:102325. doi: 10.1016/j.eclinm.2023.102325. eCollection 2023 Dec.
10
A case of pulmonary mucormycosis presented with cardiac arrest.一例肺毛霉病患者出现心脏骤停。
World J Emerg Med. 2023;14(6):484-487. doi: 10.5847/wjem.j.1920-8642.2023.096.
Type 2 Diabetes and its Impact on the Immune System.
2型糖尿病及其对免疫系统的影响。
Curr Diabetes Rev. 2020;16(5):442-449. doi: 10.2174/1573399815666191024085838.
4
Isolated Pulmonary Mucormycosis in an immunocompetent patient.免疫功能正常患者的孤立性肺毛霉菌病。
Rev Port Cir Cardiotorac Vasc. 2019 Apr-Jun;26(2):151-153.
5
Factors affecting surgical resection and treatment outcomes in patients with pulmonary mucormycosis.影响肺毛霉病患者手术切除及治疗结果的因素。
J Thorac Dis. 2019 Mar;11(3):892-900. doi: 10.21037/jtd.2019.01.75.
6
Immune Dysfunction and Albumin-Related Immunity in Liver Cirrhosis.肝硬化中的免疫功能障碍和白蛋白相关免疫。
Mediators Inflamm. 2019 Feb 25;2019:7537649. doi: 10.1155/2019/7537649. eCollection 2019.
7
Contemporary management and clinical outcomes of mucormycosis: A systematic review and meta-analysis of case reports.当代毛霉病的治疗管理和临床结局:病例报告的系统评价和荟萃分析。
Int J Antimicrob Agents. 2019 May;53(5):589-597. doi: 10.1016/j.ijantimicag.2019.01.002. Epub 2019 Jan 10.
8
A case of pulmonary mucormycosis presented as Pancoast syndrome and bone destruction in an immunocompetent adult mimicking lung carcinoma.一例肺毛霉菌病表现为 Pancoast 综合征和骨质破坏,在免疫功能正常的成人中类似于肺癌。
J Mycol Med. 2019 Apr;29(1):80-83. doi: 10.1016/j.mycmed.2018.10.005. Epub 2018 Dec 12.
9
The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports.毛霉病的流行病学和临床表现:病例报告的系统评价和荟萃分析。
Clin Microbiol Infect. 2019 Jan;25(1):26-34. doi: 10.1016/j.cmi.2018.07.011. Epub 2018 Jul 21.
10
Invasive pulmonary mucormycosis and aspergillosis in a patient with decompensated hepatic cirrhosis.一名失代偿期肝硬化患者发生的侵袭性肺毛霉病和曲霉病。
Med Mycol Case Rep. 2018 Mar 6;21:12-15. doi: 10.1016/j.mmcr.2018.03.004. eCollection 2018 Sep.